Live Breaking News & Updates on Braden Michael Leonard

Stay updated with breaking news from Braden michael leonard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Receives Consensus Rating of "Reduce" from Analysts

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Free Report) has received an average recommendation of “Reduce” from the eight research firms that are currently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and seven have issued a hold recommendation on the company. The average 1 year target […] ....

Braden Michael Leonard , Capital Management , Securities Exchange Commission , Reneo Pharmaceuticals Stock Performance , Reneo Pharmaceuticals , Highbridge Capital Management , Eventide Asset Management , News Ratings For Reneo Pharmaceuticals Daily , Analyst Recommendations For Reneo Pharmaceuticals , Marquette Asset Management , Reneo Pharmaceuticals Inc , Reneo Pharmaceuticals Company Profile , Get Free Report , Exchange Commission , Point Capital , Asset Management , Get Free , Reneo Pharmaceuticals Daily ,

HC Wainwright Reaffirms "Neutral" Rating for Reneo Pharmaceuticals (NASDAQ:RPHM)

HC Wainwright reaffirmed their neutral rating on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a research report released on Tuesday morning, Benzinga reports. The brokerage currently has a $1.50 target price on the stock. Reneo Pharmaceuticals Trading Up 5.4 % Shares of RPHM stock opened at $1.75 on Tuesday. The stock has a […] ....

Braden Michael Leonard , News Ratings For Reneo Pharmaceuticals Daily , Reneo Pharmaceuticals Trading , Reneo Pharmaceuticals Inc , Reneo Pharmaceuticals Company Profile , Reneo Pharmaceuticals , Analyst Recommendations For Reneo Pharmaceuticals , Marquette Asset Management , Capital Management , Eventide Asset Management , Highbridge Capital Management , Free Report , Get Free Report , Point Capital , Asset Management , Reneo Pharmaceuticals Daily ,

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Acquires 414,281 Shares of Stock

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM) Major Shareholder Braden Michael Leonard Acquires 414,281 Shares of Stock
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

Braden Michael Leonard , News Ratings For Reneo Pharmaceuticals Daily , Reneo Pharmaceuticals Price Performance , Reneo Pharmaceuticals , Eventide Asset Management , Reneo Pharmaceuticals Inc , Securities Exchange Commission , Sg Americas Securities , Capital Management , Get Free Report , Exchange Commission , Asset Management , Capital Partners , Pale Fire Capital , Reneo Pharmaceuticals Daily ,

AVROBIO, Inc. (NASDAQ:AVRO) Sees Significant Increase in Short Interest

AVROBIO, Inc. (NASDAQ:AVRO – Get Free Report) was the recipient of a large growth in short interest in the month of April. As of April 30th, there was short interest totalling 163,200 shares, a growth of 19.0% from the April 15th total of 137,200 shares. Currently, 0.4% of the company’s stock are sold short. Based […] ....

United States , Braden Michael Leonard , Advisor Group , Avrobio Inc , Securities Exchange Commission , Investment Advisers , Company Profile , Gabelli Funds , Aldebaran Capital , Get Free Report , Exchange Commission ,

IMARA (NASDAQ:IMRA) Downgraded by Zacks Investment Research

IMARA (NASDAQ:IMRA – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports. According to Zacks, “Imara Inc. is a biopharmaceutical company. It engages in developing and commercializing novel therapeutics to treat patients suffering from rare […] ....

United States , Braden Michael Leonard , Securities Exchange Commission , Goldman Sachs Group Inc , Zacks Investment Research , De Shaw Co , Company Profile Get Rating , York Mellon Corp , Enterprise Associates , Cubist Systematic Strategies , Imara Inc , Get Rating , Exchange Commission , Systematic Strategies , New York Mellon Corp , Sachs Group , Nasdaq Imra ,